<DOC>
	<DOC>NCT00032396</DOC>
	<brief_summary>A study evaluating Retisert in patients with age-related macular degeneration</brief_summary>
	<brief_title>A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Fluocinolone Acetonide</mesh_term>
	<criteria />
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2002</verification_date>
	<keyword>AMD</keyword>
	<keyword>ARMD</keyword>
	<keyword>Age-Related Macular Degeneration</keyword>
	<keyword>Subfoveal Choroidal Neovascularization</keyword>
	<keyword>CNV</keyword>
</DOC>